• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛果芸香碱及其他胆碱能药物在唾液腺功能障碍管理中的应用

Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction.

作者信息

Ferguson M M

机构信息

Department of Oral Medicine and Oral Surgery, University of Otago, New Zealand.

出版信息

Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):186-91. doi: 10.1016/0030-4220(93)90092-i.

DOI:10.1016/0030-4220(93)90092-i
PMID:8093976
Abstract

Sialagogues constitute an important component in the management of salivary gland dysfunction. Of the pharmacologic agents available, pilocarpine has been used extensively over the last century. Many clinical trials have documented the efficacy of this alkaloid, with doses that range from 1 to 15 mg normally taken four times a day. There is considerable individual variation in response although it is usually possible, in the presence of sufficient responsive exocrine tissue, to establish a therapeutic regimen that promotes increased salivation without significant side effects.

摘要

催涎剂是唾液腺功能障碍管理中的一个重要组成部分。在现有的药物制剂中,毛果芸香碱在过去一个世纪中得到了广泛应用。许多临床试验都证明了这种生物碱的疗效,通常剂量为1至15毫克,每天服用四次。尽管在有足够反应性外分泌组织的情况下,通常有可能建立一种能促进唾液分泌增加且无明显副作用的治疗方案,但个体反应存在相当大的差异。

相似文献

1
Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction.毛果芸香碱及其他胆碱能药物在唾液腺功能障碍管理中的应用
Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):186-91. doi: 10.1016/0030-4220(93)90092-i.
2
Systemic therapy of salivary gland hypofunction.涎腺功能减退的全身治疗
J Dent Res. 1987 Feb;66 Spec No:689-92. doi: 10.1177/00220345870660s214.
3
Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.用于治疗放疗引起的唾液腺功能障碍的拟副交感神经药物。
Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD003782. doi: 10.1002/14651858.CD003782.pub3.
4
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?唾液腺闪烁扫描术能否预测放疗后口干患者对毛果芸香碱的反应?
Eur J Nucl Med. 1999 Mar;26(3):220-5. doi: 10.1007/s002590050380.
5
Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction.毛果芸香碱用于治疗与唾液腺功能障碍相关的口干症。
Oral Surg Oral Med Oral Pathol. 1986 Mar;61(3):243-8. doi: 10.1016/0030-4220(86)90369-5.
6
Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.口服毛果芸香碱:其药理学特性及在口干症中的临床应用潜力综述
Drugs. 1995 Jan;49(1):143-55. doi: 10.2165/00003495-199549010-00010.
7
Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.用于治疗放疗引起的唾液腺功能障碍的拟副交感神经药物。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD003782. doi: 10.1002/14651858.CD003782.pub2.
8
Salivary hypofunction: An update on therapeutic strategies.唾液腺功能减退:治疗策略的最新进展
Gerodontology. 2018 Dec;35(4):305-316. doi: 10.1111/ger.12353. Epub 2018 Jun 29.
9
A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer.人工唾液与毛果芸香碱治疗晚期癌症患者口干症的比较。
Palliat Med. 1998 Mar;12(2):105-11. doi: 10.1191/026921698670435903.
10
The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy.毛果芸香碱和氯贝胆碱对放疗后唾液分泌减少的癌症患者唾液分泌的疗效。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Feb;97(2):190-5. doi: 10.1016/j.tripleo.2003.08.031.

引用本文的文献

1
Efficacy of combined administration of Baekhogainsam-Tang and low-dose pilocarpine on frequent intractable xerostomia: Study protocol for a randomized controlled trial.白芍甘草汤联合小剂量毛果芸香碱治疗频发难治性口干症的疗效:一项随机对照试验研究方案。
PLoS One. 2024 Nov 11;19(11):e0307557. doi: 10.1371/journal.pone.0307557. eCollection 2024.
2
Outline of Salivary Gland Pathogenesis of Sjögren's Syndrome and Current Therapeutic Approaches.干燥综合征唾液腺发病机制概要及当前治疗方法。
Int J Mol Sci. 2023 Jul 6;24(13):11179. doi: 10.3390/ijms241311179.
3
Muscarinics for Xerostomia in Patients with Sjögren's Syndrome.
毒蕈碱类药物用于干燥综合征患者的口腔干燥症治疗。
Clin Drug Investig. 2002 Sep;22(9):639-640. doi: 10.2165/00044011-200222090-00010.
4
Efficacy of Pilocarpine and Bromhexine in Improving Radiotherapy-induced Xerostomia.毛果芸香碱和溴己新改善放疗所致口干症的疗效
J Dent Res Dent Clin Dent Prospects. 2013;7(2):86-90. doi: 10.5681/joddd.2013.015. Epub 2013 May 30.
5
The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.抗抑郁药和毛果芸香碱对大鼠腮腺的影响:免疫组织化学研究。
Clinics (Sao Paulo). 2011;66(9):1605-10. doi: 10.1590/s1807-59322011000900017.
6
Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake.参与毛果芸香碱诱导的唾液分泌、高血压和水摄入的中枢毒蕈碱受体亚型。
Br J Pharmacol. 2008 Dec;155(8):1256-63. doi: 10.1038/bjp.2008.355. Epub 2008 Sep 29.
7
[Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].[皮肤和黏膜急性辐射相关发病率的预防与治疗。II,文献推荐]
Strahlenther Onkol. 1998 Apr;174(4):193-9. doi: 10.1007/BF03038526.
8
Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.口服毛果芸香碱:其药理学特性及在口干症中的临床应用潜力综述
Drugs. 1995 Jan;49(1):143-55. doi: 10.2165/00003495-199549010-00010.